These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19551407)

  • 1. Prognostic significance of a pretreatment hematologic profile in patients with head and neck cancer.
    Chen MH; Chang PM; Chen PM; Tzeng CH; Chu PY; Chang SY; Yang MH
    J Cancer Res Clin Oncol; 2009 Dec; 135(12):1783-90. PubMed ID: 19551407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment count of peripheral neutrophils, monocytes, and lymphocytes as independent prognostic factor in patients with head and neck cancer.
    Valero C; Pardo L; López M; García J; Camacho M; Quer M; León X
    Head Neck; 2017 Feb; 39(2):219-226. PubMed ID: 27534525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of nutritional and hematologic markers in head and neck squamous cell carcinoma treated by chemoradiotherapy.
    Moon H; Roh JL; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
    Radiother Oncol; 2016 Feb; 118(2):330-4. PubMed ID: 26653356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of serum lipid profile and its prognostic value in head and neck squamous cell carcinoma.
    Li G; Da M; Zhang W; Wu H; Ye J; Chen J; Ma L; Gu N; Wu Y; Song X
    J Oral Pathol Med; 2016 Mar; 45(3):167-72. PubMed ID: 26189546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of pretreatment platelet count in patients with head and neck squamous cell carcinoma.
    Pardo L; Valero C; López M; García J; Camacho M; Quer M; León X
    Auris Nasus Larynx; 2017 Jun; 44(3):313-318. PubMed ID: 27401121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic inflammatory markers as independent prognosticators of head and neck squamous cell carcinoma.
    Rassouli A; Saliba J; Castano R; Hier M; Zeitouni AG
    Head Neck; 2015 Jan; 37(1):103-10. PubMed ID: 24339165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment albumin level predicts survival in head and neck squamous cell carcinoma.
    Lim WS; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
    Laryngoscope; 2017 Dec; 127(12):E437-E442. PubMed ID: 28561532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower circulating platelet counts and antiplatelet therapy independently predict better outcomes in patients with head and neck squamous cell carcinoma.
    Rachidi S; Wallace K; Day TA; Alberg AJ; Li Z
    J Hematol Oncol; 2014 Sep; 7():65. PubMed ID: 25260646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemoglobin as an independent prognostic factor in the radiotherapy of head and neck tumors.
    Schäfer U; Micke O; Müller SB; Schüller P; Willich N
    Strahlenther Onkol; 2003 Aug; 179(8):527-34. PubMed ID: 14509951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil-to-lymphocyte ratio: Prognostic indicator for head and neck squamous cell carcinoma.
    Rosculet N; Zhou XC; Ha P; Tang M; Levine MA; Neuner G; Califano J
    Head Neck; 2017 Apr; 39(4):662-667. PubMed ID: 28075517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment High MCV as Adverse Prognostic Marker in Nonanemic Patients with Head and Neck Cancer.
    Borsetto D; Polesel J; Tirelli G; Menegaldo A; Baggio V; Gava A; Nankivell P; Pracy P; Fussey J; Boscolo-Rizzo P
    Laryngoscope; 2021 Mar; 131(3):E836-E845. PubMed ID: 32589769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of serum squamous cell carcinoma antigen in patients with head and neck cancer.
    Imai R; Takenaka Y; Yasui T; Nakahara S; Yamamoto Y; Hanamoto A; Takemoto N; Fukusumi T; Cho H; Yamamoto M; Inohara H
    Acta Otolaryngol; 2015 Mar; 135(3):295-301. PubMed ID: 25622661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results of radiation therapy oncology group 9903: a randomized phase 3 trial to assess the effect of erythropoietin on local-regional control in anemic patients treated with radiation therapy for squamous cell carcinoma of the head and neck.
    Shenouda G; Zhang Q; Ang KK; Machtay M; Parliament MB; Hershock D; Suntharalingam M; Lin A; Rotman M; Nabid A; Hong S; Shehata S; Cmelak AJ; Sultanem K; Le QT
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):907-15. PubMed ID: 25670542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the Royal Marsden Hospital prognostic score in patients treated in the Phase I Clinical Trials Program at the MD Anderson Cancer Center.
    Garrido-Laguna I; Janku F; Vaklavas C; Falchook GS; Fu S; Hong DS; Naing A; Tsimberidou AM; Wen S; Kurzrock R
    Cancer; 2012 Mar; 118(5):1422-8. PubMed ID: 21823111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neutrophil to lymphocyte ratio in peripheral blood: a novel independent prognostic factor in patients with head and neck squamous cell carcinoma].
    Wu F; Wu LL; Zhu LX
    Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):29-32. PubMed ID: 28104030
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic relevance of insulin resistance on disease-free survival in head and neck squamous cell carcinomas: Preliminary results.
    Avilés-Jurado FX; Flores JC; Gumà J; Ceperuelo-Mallafré V; Casanova-Marqués R; Gómez D; Vendrell JJ; León X; Vilaseca I; Terra X
    Head Neck; 2017 Dec; 39(12):2501-2511. PubMed ID: 28963801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Type 2 Diabetes Mellitus on Survival in Head and Neck Squamous Cell Carcinoma.
    Foreman A; Lee DJ; McMullen C; de Almeida J; Muhanna N; Gama RR; Giuliani M; Liu G; Bratman SV; Huang SH; O'Sullivan B; Song Y; Xu W; Goldstein DP
    Otolaryngol Head Neck Surg; 2017 Oct; 157(4):657-663. PubMed ID: 28849730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment lymphocyte-to-monocyte ratio as an independent prognostic factor for head and neck cancer.
    Kano S; Homma A; Hatakeyama H; Mizumachi T; Sakashita T; Kakizaki T; Fukuda S
    Head Neck; 2017 Feb; 39(2):247-253. PubMed ID: 27617428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment dietary patterns, weight status, and head and neck squamous cell carcinoma prognosis.
    Arthur AE; Peterson KE; Rozek LS; Taylor JM; Light E; Chepeha DB; Hébert JR; Terrell JE; Wolf GT; Duffy SA;
    Am J Clin Nutr; 2013 Feb; 97(2):360-8. PubMed ID: 23269814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the prognostic utility of the hemoglobin-to-red cell distribution width ratio in head and neck cancer.
    Tham T; Olson C; Wotman M; Teegala S; Khaymovich J; Coury J; Costantino P
    Eur Arch Otorhinolaryngol; 2018 Nov; 275(11):2869-2878. PubMed ID: 30251123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.